Q3 2023 · 13F-HR
TANG CAPITAL MANAGEMENT LLCholdings as filed
Filed 2023-11-14 · accession 0001214659-23-015104
$708.7M
Reported value
106
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $38.0M | 5.37% | 2,140,586 | Common | SHARED |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $35.9M | 5.07% | 1,137,107 | Common | SHARED |
| 032724106 | ANAB | ANAPTYSBIO INC | $35.0M | 4.94% | 1,950,609 | Common | SHARED |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $33.1M | 4.67% | 3,440,345 | Common | SHARED |
| 30052C107 | EOLS | EVOLUS INC | $28.3M | 3.99% | 3,097,399 | Common | SHARED |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $23.8M | 3.36% | 1,500,000 | Common | SHARED |
| 26886C107 | — | EQRX INC | $22.4M | 3.16% | 10,086,110 | Common | SHARED |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $22.4M | 3.16% | 320,000 | Common | SHARED |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $21.1M | 2.97% | 405,600 | Common | SHARED |
| 649445103 | NYCBEUR | NEW YORK CMNTY BANCORP INC | $18.2M | 2.57% | 1,606,600 | Common | SHARED |
| 532457108 | LLY | ELI LILLY & CO | $16.1M | 2.27% | 30,000 | Common | SHARED |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $15.6M | 2.21% | 300,000 | Common | SHARED |
| 92243G108 | PCVX | VAXCYTE INC | $15.3M | 2.16% | 300,000 | Common | SHARED |
| 07725L102 | ONC | BEIGENE LTD | $15.3M | 2.16% | 85,000 | Common | SHARED |
| 09609G100 | — | BLUEBIRD BIO INC | $13.0M | 1.84% | 4,282,827 | Common | SHARED |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $12.7M | 1.80% | 1,800,000 | Common | SHARED |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $12.6M | 1.77% | 397,600 | Common | SHARED |
| 046353108 | AZNN | ASTRAZENECA PLC | $11.5M | 1.62% | 170,000 | Common | SHARED |
| 88427A107 | — | THIRD HARMONIC BIO INC | $11.5M | 1.62% | 1,800,000 | Common | SHARED |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $10.8M | 1.52% | 3,600,000 | Common | SHARED |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $10.4M | 1.47% | 600,000 | Common | SHARED |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $10.3M | 1.45% | 1,000,000 | Common | SHARED |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $10.3M | 1.45% | 669,125 | Common | SHARED |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $9.1M | 1.28% | 200,000 | Common | SHARED |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $8.9M | 1.25% | 271,200 | Common | SHARED |
| 090572207 | BIO | BIO RAD LABS INC | $8.6M | 1.21% | 24,000 | Common | SHARED |
| N44821101 | IFRX | INFLARX NV | $8.4M | 1.19% | 2,824,353 | Common | SHARED |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $8.3M | 1.17% | 6,450,000 | Common | SHARED |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $8.1M | 1.14% | 591,636 | Common | SHARED |
| G6674U108 | NVCR | NOVOCURE LTD | $7.9M | 1.12% | 492,100 | Common | SHARED |
| 60770K107 | MRNA | MODERNA INC | $7.9M | 1.12% | 76,700 | Common | SHARED |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $7.8M | 1.11% | 180,000 | Common | SHARED |
| 92337C203 | VSTM | VERASTEM INC | $7.2M | 1.02% | 891,514 | Common | SHARED |
| 02155H200 | ALT | ALTIMMUNE INC | $7.2M | 1.01% | 2,750,000 | Common | SHARED |
| 98985Y108 | ZYME | ZYMEWORKS INC | $7.0M | 0.98% | 1,100,000 | Common | SHARED |
| 09077B104 | BCABGBP | BIOATLA INC | $6.4M | 0.91% | 3,778,393 | Common | SHARED |
| N90064101 | QURE | UNIQURE NV | $6.3M | 0.89% | 935,800 | Common | SHARED |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $5.8M | 0.82% | 750,000 | Common | SHARED |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $5.6M | 0.79% | 621,138 | Common | SHARED |
| 294628102 | HP5A | EQUITY COMWLTH | $5.5M | 0.78% | 300,000 | Common | SHARED |
| 05455M100 | — | AVROBIO INC | $5.4M | 0.76% | 3,512,686 | Common | SHARED |
| 023111206 | — | AMARIN CORP PLC | $5.4M | 0.76% | 5,862,517 | Common | SHARED |
| 38870X104 | GRPH | GRAPHITE BIO INC | $5.0M | 0.71% | 2,016,626 | Common | SHARED |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $4.9M | 0.69% | 1,360,000 | Common | SHARED |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $4.4M | 0.63% | 300,000 | Common | SHARED |
| 457669307 | INSM | INSMED INC | $4.2M | 0.59% | 166,203 | Common | SHARED |
| 172967424 | C | CITIGROUP INC | $4.1M | 0.58% | 100,000 | Common | SHARED |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $4.0M | 0.57% | 5,166,954 | Common | SHARED |
| 22053A107 | — | QUINCE THERAPEUTICS INC | $3.9M | 0.55% | 3,498,868 | Common | SHARED |
| 923451108 | VBTX | VERITEX HLDGS INC | $3.8M | 0.53% | 210,000 | Common | SHARED |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $3.7M | 0.52% | 3,557,040 | Common | SHARED |
| G1110E107 | BHVN | BIOHAVEN LTD | $3.6M | 0.51% | 140,000 | Common | SHARED |
| 04522R200 | — | ASLAN PHARMACEUTICALS LTD | $3.6M | 0.50% | 1,901,552 | Common | SHARED |
| 372279109 | GNFTY | GENFIT S A | $3.4M | 0.48% | 1,040,636 | Common | SHARED |
| 126600105 | CVBF | CVB FINL CORP | $3.3M | 0.47% | 200,000 | Common | SHARED |
| 902973304 | USB | US BANCORP DEL | $3.3M | 0.47% | 100,000 | Common | SHARED |
| 75082Q105 | — | RAIN ONCOLOGY INC | $3.2M | 0.45% | 3,740,341 | Common | SHARED |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $3.2M | 0.45% | 1,350,000 | Common | SHARED |
| 36315X101 | LKFT | GALAPAGOS NV | $3.1M | 0.44% | 89,650 | Common | SHARED |
| 294100102 | ENZB | ENZO BIOCHEM INC | $3.1M | 0.43% | 2,200,000 | Common | SHARED |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $3.1M | 0.43% | 150,000 | Common | SHARED |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $3.0M | 0.42% | 200,000 | Common | SHARED |
| 53000N108 | LIANY | LIANBIO | $2.7M | 0.38% | 1,800,000 | Common | SHARED |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $2.7M | 0.37% | 4,000,000 | Common | SHARED |
| 01626L105 | — | ALIGOS THERAPEUTICS INC | $2.5M | 0.35% | 3,329,048 | Common | SHARED |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $2.3M | 0.33% | 3,939,600 | Common | SHARED |
| 55279B301 | LITS | MEI PHARMA INC | $2.3M | 0.32% | 326,084 | Common | SHARED |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $2.3M | 0.32% | 200,000 | Common | SHARED |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $2.1M | 0.29% | 100,000 | Common | SHARED |
| 70465T107 | PDSB | PDS BIOTECHNOLOGY CORP | $2.0M | 0.29% | 400,000 | Common | SHARED |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $1.9M | 0.27% | 1,850,000 | Common | SHARED |
| 09063M205 | BNOXN | BIONOMICS LIMITED | $1.9M | 0.27% | 700,000 | Common | SHARED |
| 269796108 | EGRX | EAGLE PHARMACEUTICALS INC | $1.9M | 0.26% | 118,857 | Common | SHARED |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $1.8M | 0.26% | 1,850,000 | Common | SHARED |
| 48576A100 | — | KARUNA THERAPEUTICS INC | $1.7M | 0.24% | 10,000 | Common | SHARED |
| 007002108 | TORCEUR | ADICET BIO INC | $1.7M | 0.24% | 1,226,352 | Common | SHARED |
| 48115J109 | DERM | JOURNEY MED CORP | $1.6M | 0.22% | 576,100 | Common | SHARED |
| 04335A105 | ARVN | ARVINAS INC | $1.6M | 0.22% | 80,000 | Common | SHARED |
| 81768T108 | SFBS | SERVISFIRST BANCSHARES INC | $1.6M | 0.22% | 30,000 | Common | SHARED |
| 28106W103 | EDIT | EDITAS MEDICINE INC | $1.6M | 0.22% | 200,000 | Common | SHARED |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $1.5M | 0.22% | 409,463 | Common | SHARED |
| 65487U108 | NKTX | NKARTA INC | $1.5M | 0.22% | 1,103,638 | Common | SHARED |
| 19249H103 | CHRS | COHERUS BIOSCIENCES INC | $1.5M | 0.21% | 400,000 | Common | SHARED |
| 062540109 | BOH | BANK HAWAII CORP | $1.5M | 0.21% | 30,000 | Common | SHARED |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $1.5M | 0.21% | 700,000 | Common | SHARED |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $1.1M | 0.16% | 400,000 | Common | SHARED |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $936,400 | 0.13% | 10,000 | Common | SHARED |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $836,000 | 0.12% | 100,000 | Common | SHARED |
| 002120202 | ATYR | ATYR PHARMA INC | $744,392 | 0.11% | 471,134 | Common | SHARED |
| 04746L104 | — | ATHIRA PHARMA INC | $712,484 | 0.10% | 352,715 | Common | SHARED |
| 38341P102 | GOSS | GOSSAMER BIO INC | $698,386 | 0.10% | 838,600 | Common | SHARED |
| 65443P102 | MASS | 908 DEVICES INC | $666,000 | 0.09% | 100,000 | Common | SHARED |
| 00534A102 | IVVD | INVIVYD INC | $623,111 | 0.09% | 366,536 | Common | SHARED |
| 45791E107 | — | INSPIRATO INCORPORATED | $516,590 | 0.07% | 875,577 | Common | SHARED |
| 65343E108 | NXTCEUR | NEXTCURE INC | $516,000 | 0.07% | 400,000 | Common | SHARED |
| 38406L103 | — | GRACELL BIOTECHNOLOGIES INC | $458,171 | 0.06% | 159,087 | Common | SHARED |
| 858927106 | STEL | STELLAR BANCORP INC | $426,400 | 0.06% | 20,000 | Common | SHARED |
| 816212104 | SELBUSD | SELECTA BIOSCIENCES INC | $424,000 | 0.06% | 400,000 | Common | SHARED |
| 60853G106 | MOLN | MOLECULAR PARTNERS AG | $414,000 | 0.06% | 100,000 | Common | SHARED |
| 29446K106 | EQ | EQUILLIUM INC | $296,000 | 0.04% | 400,000 | Common | SHARED |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $279,000 | 0.04% | 150,000 | Common | SHARED |
| 64131A105 | STIM | NEURONETICS INC | $270,000 | 0.04% | 200,000 | Common | SHARED |
| 702712100 | — | PASSAGE BIO INC | $263,200 | 0.04% | 400,000 | Common | SHARED |
| 81663L200 | WGS | GENEDX HOLDINGS CORP | $231,636 | 0.03% | 63,636 | Common | SHARED |
| 00444T209 | TLPH | ACELRX PHARMACEUTICALS INC | $113,100 | 0.02% | 195,000 | Common | SHARED |
| 89357L204 | — | TRANSCODE THERAPEUTICS INC | $42,232 | 0.01% | 84,010 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.